N

Navamedic ASA
OSE:NAVA

Watchlist Manager
Navamedic ASA
OSE:NAVA
Watchlist
Price: 23.5 NOK -2.08% Market Closed
Market Cap: 415.1m NOK
Have any thoughts about
Navamedic ASA?
Write Note

Intrinsic Value

The intrinsic value of one NAVA stock under the Base Case scenario is 55.24 NOK. Compared to the current market price of 23.5 NOK, Navamedic ASA is Undervalued by 57%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

NAVA Intrinsic Value
55.24 NOK
Undervaluation 57%
Intrinsic Value
Price
N
Worst Case
Base Case
Best Case

Valuation Backtest
Navamedic ASA

Backtest Intrinsic Value
Dive into the past to invest in the future

Uncover deeper insights with the Valuation Backtest. Learn how current stock valuations stack up against historical averages to gauge true investment potential.

Start backtest now and learn if your stock is truly undervalued or overvalued!

Run Backtest
Backtest Conclusion
Very Attractive
Current Valuation
+45%
Avg Valuation
-12%
Worst Valuation
-49%
Best Valuation
+45%

Stock is trading at its lowest valuation over the past 5 years.

Backtest Example
Register to View Results
Register to View Results

To access the results of this valuation backtest, please register an account with us. Registration is quick and gives you instant access to insights on 3 stocks per week for free.

Backtest Unavailable

The backtest for NAVA cannot be conducted due to limitations such as insufficient data or other constraints. Please select a different stock or adjust your settings.

Backtest In Progress...
Backtest In Progress...
How do you feel about NAVA?
Bearish
Neutral
Bullish

Fundamental Analysis

Risks & Rewards

 

 

 

 

View All Risks & Rewards
Company Quality
No Indicators Selected
Select Indicators

Select up to 3 indicators:

Insider Trading
0-3
Months
0-6
Months
0-12
Months
0-36
Months
No Periods Selected
Select Periods

Select up to 2 periods:

Notes
AI Assistant
AI Assistant
Ask me anything about Navamedic ASA

Provide an overview of the primary business activities
of Navamedic ASA.

What unique competitive advantages
does Navamedic ASA hold over its rivals?

What risks and challenges
does Navamedic ASA face in the near future?

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for Navamedic ASA.

Provide P/S
for Navamedic ASA.

Provide P/E
for Navamedic ASA.

Provide P/OCF
for Navamedic ASA.

Provide P/FCFE
for Navamedic ASA.

Provide P/B
for Navamedic ASA.

Provide EV/S
for Navamedic ASA.

Provide EV/GP
for Navamedic ASA.

Provide EV/EBITDA
for Navamedic ASA.

Provide EV/EBIT
for Navamedic ASA.

Provide EV/OCF
for Navamedic ASA.

Provide EV/FCFF
for Navamedic ASA.

Provide EV/IC
for Navamedic ASA.

Show me price targets
for Navamedic ASA made by professional analysts.

What are the Revenue projections
for Navamedic ASA?

How accurate were the past Revenue estimates
for Navamedic ASA?

What are the Net Income projections
for Navamedic ASA?

How accurate were the past Net Income estimates
for Navamedic ASA?

What are the EPS projections
for Navamedic ASA?

How accurate were the past EPS estimates
for Navamedic ASA?

What are the EBIT projections
for Navamedic ASA?

How accurate were the past EBIT estimates
for Navamedic ASA?

Compare the revenue forecasts
for Navamedic ASA with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of Navamedic ASA and its key competitors using the latest financial data.

Compare historical revenue growth rates
of Navamedic ASA against its competitors.

Analyze the profit margins
(gross, operating, and net) of Navamedic ASA compared to its peers.

Compare the P/E ratios
of Navamedic ASA against its peers.

Discuss the investment returns and shareholder value creation
comparing Navamedic ASA with its peers.

Analyze the financial leverage
of Navamedic ASA compared to its main competitors.

Show all profitability ratios
for Navamedic ASA.

Provide ROE
for Navamedic ASA.

Provide ROA
for Navamedic ASA.

Provide ROIC
for Navamedic ASA.

Provide ROCE
for Navamedic ASA.

Provide Gross Margin
for Navamedic ASA.

Provide Operating Margin
for Navamedic ASA.

Provide Net Margin
for Navamedic ASA.

Provide FCF Margin
for Navamedic ASA.

Show all solvency ratios
for Navamedic ASA.

Provide D/E Ratio
for Navamedic ASA.

Provide D/A Ratio
for Navamedic ASA.

Provide Interest Coverage Ratio
for Navamedic ASA.

Provide Altman Z-Score Ratio
for Navamedic ASA.

Provide Quick Ratio
for Navamedic ASA.

Provide Current Ratio
for Navamedic ASA.

Provide Cash Ratio
for Navamedic ASA.

What is the historical Revenue growth
over the last 5 years for Navamedic ASA?

What is the historical Net Income growth
over the last 5 years for Navamedic ASA?

What is the current Free Cash Flow
of Navamedic ASA?

Discuss the annual earnings per share (EPS)
trend over the past five years for Navamedic ASA.

Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
Navamedic ASA

Current Assets 289.4m
Cash & Short-Term Investments 30.2m
Receivables 145.3m
Other Current Assets 113.9m
Non-Current Assets 258m
PP&E 9.4m
Intangibles 247.7m
Other Non-Current Assets 931k
Current Liabilities 200.5m
Accounts Payable 73.4m
Other Current Liabilities 127.1m
Non-Current Liabilities 102.8m
Long-Term Debt 90m
Other Non-Current Liabilities 12.8m
Efficiency

Earnings Waterfall
Navamedic ASA

Revenue
543.5m NOK
Cost of Revenue
-325.9m NOK
Gross Profit
217.6m NOK
Operating Expenses
-170.1m NOK
Operating Income
47.5m NOK
Other Expenses
-22.8m NOK
Net Income
24.6m NOK

Free Cash Flow Analysis
Navamedic ASA

Last Value
3-Years Average
FCF Margin
Conversion Rate
Fundamental Scores

NAVA Profitability Score
Profitability Due Diligence

Navamedic ASA's profitability score is 55/100. The higher the profitability score, the more profitable the company is.

Exceptional 3-Years Revenue Growth
Positive Gross Profit
ROE is Increasing
Positive Revenue Growth Forecast
55/100
Profitability
Score

Navamedic ASA's profitability score is 55/100. The higher the profitability score, the more profitable the company is.

NAVA Solvency Score
Solvency Due Diligence

Navamedic ASA's solvency score is 49/100. The higher the solvency score, the more solvent the company is.

Low D/E
Long-Term Solvency
Short-Term Solvency
Average Altman Z-Score
49/100
Solvency
Score

Navamedic ASA's solvency score is 49/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

NAVA Price Targets Summary
Navamedic ASA

Wall Street analysts forecast NAVA stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for NAVA is 45.39 NOK with a low forecast of 43.43 NOK and a high forecast of 48.3 NOK.

Lowest
Price Target
43.43 NOK
85% Upside
Average
Price Target
45.39 NOK
93% Upside
Highest
Price Target
48.3 NOK
106% Upside
View Analyst Estimates
View Analyst Estimates
Want to learn more about Wall St estimates for NAVA?

Click here to dive deeper.

Dividends

Dividend Yield
Lowest
Average
Highest
Dividend Per Share
N/A
Growth 3Y
Growth 5Y
Growth 10Y
Dividend Safety Score
Very
Unsafe
Unsafe
Safe
Very
Safe
0
25
50
75
100
Shareholder Yield

Current shareholder yield for NAVA is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
Lowest
Average
Highest
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Profile

Navamedic ASA

Country

Norway

Industry

Pharmaceuticals

Market Cap

409.7m NOK

Dividend Yield

0%

Description

Navamedic ASA engages in the delivery and marketing of pharmaceutical products to patients, hospitals, and pharmacies. The company is headquartered in Oslo, Oslo. The company went IPO on 2006-03-31. The firm in-licenses, acquires and markets pharmaceuticals and other healthcare products in northern Europe. The product portfolio includes original and generic pharmaceuticals, as well as food supplements, medical devices and other healthcare products. Navamedic ASA has three subsidiaries: Observe Medical, a Swedish medical technology company; Vitaflo Scandinavia AB, which focuses on in-licensing and buying pharmaceuticals and other healthcare products within a few selected knowledge areas; and Navamedic ehf, which builds its business around the sales and marketing of generic pharmaceuticals targeted towards the Nordic and BeNeLux markets. The Navamedic business unit is built upon the cooperation with the South African pharmaceutical company Aspen Healthcare. The Company’s largest shareholder is Nobelsystem Scandinavia.

Contact

OSLO
Oslo
Henrik Ibsensgate 90
+4767112540.0
www.navamedic.com

IPO

2006-03-31

Employees

-

Officers

Chief Executive Officer
Ms. Kathrine E. Gamborg Andreassen
Chief Financial Officer
Mr. Lars Hjarrand
Chief Operating Officer
Mr. Alexander Lidmejer
Chief Scientific Officer
Ms. Astrid J. Torgersen Bratvedt
Chief Business Development Officer
Mr. Ole Henrik Eriksen

See Also

Discover More
What is the Intrinsic Value of one NAVA stock?

The intrinsic value of one NAVA stock under the Base Case scenario is 55.24 NOK.

Is NAVA stock undervalued or overvalued?

Compared to the current market price of 23.5 NOK, Navamedic ASA is Undervalued by 57%.

Back to Top